Living systematic review for WHO: casirivimab-imdevimab probably reduces hospitalization in persons with nonsevere COVID-19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Living Systematic Review for WHO: Casirivimab-imdevimab Probably Reduces Hospitalization in Persons With Nonsevere COVID-19." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315505/all/Living_systematic_review_for_WHO:_casirivimab_imdevimab_probably_reduces_hospitalization_in_persons_with_nonsevere_COVID_19.
Living systematic review for WHO: casirivimab-imdevimab probably reduces hospitalization in persons with nonsevere COVID-19. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315505/all/Living_systematic_review_for_WHO:_casirivimab_imdevimab_probably_reduces_hospitalization_in_persons_with_nonsevere_COVID_19. Accessed February 16, 2025.
Living systematic review for WHO: casirivimab-imdevimab probably reduces hospitalization in persons with nonsevere COVID-19. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315505/all/Living_systematic_review_for_WHO:_casirivimab_imdevimab_probably_reduces_hospitalization_in_persons_with_nonsevere_COVID_19
Living Systematic Review for WHO: Casirivimab-imdevimab Probably Reduces Hospitalization in Persons With Nonsevere COVID-19 [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315505/all/Living_systematic_review_for_WHO:_casirivimab_imdevimab_probably_reduces_hospitalization_in_persons_with_nonsevere_COVID_19.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Living systematic review for WHO: casirivimab-imdevimab probably reduces hospitalization in persons with nonsevere COVID-19
ID - 1315505
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315505/all/Living_systematic_review_for_WHO:_casirivimab_imdevimab_probably_reduces_hospitalization_in_persons_with_nonsevere_COVID_19
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -